Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome

Abstract
Invasive pulmonary aspergillosis (IPA) is the leading invasive fungal disease in high-risk hematologic patients, including those with acute myeloid leukemia (AML) receiving chemotherapy for induction of remission, and allogeneic hematopoietic cell transplant (HCT) recipients.[1][1],[2][2] Studies

This publication has 19 references indexed in Scilit: